NDC 50090-5033
INVOKANA
Canagliflozin
INVOKANA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Canagliflozin.
| Product ID | 50090-5033_408b1519-7007-4841-b67f-4f7fce5241a4 |
| NDC | 50090-5033 |
| Product Type | Human Prescription Drug |
| Proprietary Name | INVOKANA |
| Generic Name | Canagliflozin |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2013-03-29 |
| Marketing Category | NDA / NDA |
| Application Number | NDA204042 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | CANAGLIFLOZIN |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 50090-5033-0
90 TABLET, FILM COATED in 1 BOTTLE (50090-5033-0)
| Marketing Start Date | 2020-05-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 50090-5033-1 [50090503301]
INVOKANA TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA204042 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-05-05 |
NDC 50090-5033-0 [50090503300]
INVOKANA TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA204042 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-05-01 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| CANAGLIFLOZIN | 100 mg/1 |
Pharmacological Class
- Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
- Sodium-Glucose Transporter 2 Inhibitors [MoA]
- P-Glycoprotein Inhibitors [MoA]
NDC Crossover Matching brand name "INVOKANA" or generic name "Canagliflozin"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50090-4364 | INVOKANA | canagliflozin |
| 50090-5029 | INVOKANA | canagliflozin |
| 50090-5033 | INVOKANA | canagliflozin |
| 50090-5034 | INVOKANA | canagliflozin |
| 50458-140 | INVOKANA | canagliflozin |
| 50458-141 | INVOKANA | canagliflozin |
| 55154-1425 | INVOKANA | canagliflozin |
| 55154-1426 | INVOKANA | canagliflozin |
Trademark Results [INVOKANA]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 INVOKANA 85592280 4369669 Live/Registered |
JOHNSON & JOHNSON 2012-04-09 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.